Neurofilament proteins have been validated as specific body fluid biomarkers of neuro-
axonal injury. The advent of highly sensitive analytical platforms that enable reliable …

Fatigue is one of the most disabling symptoms of Multiple Sclerosis (MS), affecting more
than 80% of patients over the disease course. Nevertheless, it has a multi-faceted and …

Recent advances in the field of artificial intelligence (AI) could yield new insights into the
potential causes of multiple sclerosis (MS) and factors influencing its course as the use of AI …

Multiple sclerosis (MS) as a chronic, degenerative autoimmune disease of the central
nervous system has a longitudinal and heterogeneous course with increasing treatment …

Background In the early stages of multiple sclerosis (MS), there are no objective sensitive
functional assessments to identify and quantify early subclinical neuromuscular deficits and …

Background: Multiple sclerosis (MS) is a disease of the central nervous system
characterized by inflammation, demyelination, and axonal degeneration. This study aimed to …

Introduction Multiple sclerosis (MS) is a disabling disease with unpredictable clinical
manifestations. As clinical assessments may not fully capture the impact of MS on quality of …

We appreciate Zettl et al.'s 1 insightful observations and reflections in their correspondence
to our paper “Consensus quality indicators for monitoring multiple sclerosis”. 2 We value any …

Background: With a rising number of multiple sclerosis (MS) cases and increasing pressure
on health systems, digital companion apps like Brisa, designed specifically for people with …

Die ambulante spezialfachärztliche Versorgung (ASV) ist ein Behandlungsangebot an
Menschen mit seltenen Erkrankungen oder Erkrankungen mit besonderen …